Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer

Blood

Volumn 87, Issue 3, 1996, Pages 1097-1103

  Magni, Michele ^b   Shammah, Suzy ^b   Schiró, Raffaella ^b   Mellado, Wilfredo ^b   Dalla Favera, Riccardo ^a   Gianni, A Massimo ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CYCLOPHOSPHAMIDE; DISULFIRAM; MAFOSFAMIDE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030024868     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1097.bloodjournal8731097     Document Type: Article

References (36)

1. Keating A: Autologous bone marrow transplantation, in Armitage JO, Antman KH (eds): High-Dose Chemotherapy. Philadelphia, PA, Williams and Wilkins, 1992
2. Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L, Bonadonna G: Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicit and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin lymphoma. J Clin Oncol 8:768, 1990
3. Vadhan-Raj S, Buescher S, LeMaistre A, Keating A, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JU: Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72:134, 1988
4. + cells. Blood 84:1408, 1994
5. Simonsen CC, Levinson AD: Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci USA 80:2495, 1983
6. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC: A retrovirus carrying and MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486, 1988
7. Corey CA, De Silva AD, Holland CA, Williams DA: Serial transplantation of methotrexate-resistant bone marrow: Protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 75:337, 1990
8. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99, 1992
9. Gianni AM, Siena S, Bregni M, Lombardi F, Gandola L, Di Nicola M, Magni M, Peccatori F, Valagussa P, Bonadonna G: Highdose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease - A 6-year update. Ann Oncol 4:889, 1993
10. Hilton J: Role of aldehyde-dehyrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res 44-5156, 1984
11. Russo JE, Hilton J: Characterization of cytosolic aldehyde-dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res 48:2963, 1988
12. Kohn FR, Sladek N: Aldehyde-dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. Biochem Pharmacol 34:3465, 1985
13. Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CI, Hilton J: Direct demonstration of elevated aldehyde-dehydrogenase in human hematopoietic progenitor cells. Blood 75:1947, 1990
14. Hsu LC, Tani K, Fujiyoshi T, Kurachi K, Yoshida A: Cloning of cDNAs for human aldehyde-dehydrogenase 1 and 2. Proc Natl Acad Sci USA 82:3771, 1985
15. Hsu LC, Chang WC, Yoshida A: Genomic structure of the human cytosolic aldehyde-dehydrogenase gene. Genomics 5:857, 1989
16. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
17. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E: Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 86:3529, 1989
18. Sambrook J, Fritsch EF, Maniatis T (eds): Molecular Cloning : A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
19. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85.6460, 1988
20. Ventura GJ, Hester JP, Buescher ES, Vadhan-Raj S, Durrett A, Reading CL: Hematopoiesis in limiting dilution cultures: Influence of cytokines on human hematopoietic progenitor cells. Exp Hemat 18:878, 1990
21. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral mediated-gene transfer. Blood 80:1418, 1992
22. Kaizer H, Stuart RK, Brookmeyer R, Bescorner WE, Braine HG, Burns WH, Fuller DJ, Korbling M, Mangan KF, Saral R, Sensenbrenner L, Shadduck RK, Shende AC, Tutschka PJ, Yeager AM, Zinkham WH, Colvin OM, Santos GW. Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65.1504, 1985
23. Bagge Hansen M, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203, 1989
24. Finney DJ: Probit Analysis. London, UK, Cambridge University, 1952
25. Sladek NE, Landkamer GJ: Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde-dehydrogenase activity in cultured oxazaphosphorines-resistant L1210 and cross-linking agent resistant P388 cell lines. Cancer Res 45:1549, 1985
26. Kohn FR, Landkamer GJ, Manthey CL, Ramsay NKC, Sladek NE: Effect of aidehyde-dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 47:3180, 1987
27. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680, 1970
28. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications Proc Natl Acad Sci USA 76:4350, 1979
29. Yoshida A, Dave' V, Ward RJ, Peters TJ : Cytosolic aldehyde-dehydrogenase (ALDH1) variants found in alcohol flushers. Ann Hum Genet 53:1, 1989
30. Berenson RJ, Besinger WI, Kalamasz DF, Heimfeld S, Goffe RA, Berninger RW, Peterson DR, Thompson P, Strong DM: Transplantation of stem cells enriched by immunoadsorption, in: Advances in Bone Marrow Purging and Processing. New York, NY, Wiley-Liss, 1992, p 449
31. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991
32. Peters RH, Ballard K, Oatis JE, Jollow DJ, Stuart RK: Cellular glutathione as a protective agent against 4-hydroxycyclophosphamide cytotoxicity in K562 cells. Cancer Chemother Pharmacol 26:397, 1990
33. Dirven HAAM, van Ommen B, van Bladeren PJ: Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res 54:6215, 1994
34. Chan KK, Hong PS, Tutsch K, Trump DL: Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508, Cancer Res 54:6421, 1994
35. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 2:580, 1989
36. Smith IE, Evans BD, Harland SJ, Millar JL: Autologous bone marrow rescue is unnecessary after high-dose cyclophosphamide. Lancet 1.76, 1983